|
|
|
Insider
Information: |
Schuler Jack W |
Relationship: |
|
City: |
Lake Forest |
State: |
IL |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
13 |
|
Direct
Shares |
27,956,178 |
|
Indirect Shares
|
61,134,751 |
|
|
Direct
Value |
$198,559,401 |
|
|
Indirect Value
|
$175,231,488 |
|
|
Total
Shares |
89,090,929 |
|
|
Total
Value |
$373,790,889 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
54
|
96
|
Stock
price went up :
|
14
|
2
|
Stock
price went down : |
40
|
94
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-25.7%
|
-5,816.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 17 of 26
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
YTEN |
Yield10 Bioscience Inc |
10% Owner |
|
2020-02-10 |
4 |
S |
$7.90 |
$223,180 |
I/I |
(28,256) |
471,093 |
0 |
% |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2014-07-01 |
4 |
B |
$25.70 |
$223,539 |
I/I |
8,698 |
10,658,690 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2018-12-19 |
4 |
A |
$11.21 |
$224,200 |
I/I |
20,000 |
1,884,423 |
0 |
- |
|
VMSI |
Ventana Medical Systems I... |
Director |
|
2003-11-21 |
4 |
B |
$35.29 |
$229,700 |
D/D |
6,500 |
1,021,664 |
2.39 |
- |
|
ONCT |
Oncternal Therapeutics In... |
Director |
|
2012-03-01 |
4 |
B |
$3.33 |
$232,101 |
D/D |
69,700 |
5,632,320 |
3.92 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2016-02-08 |
4 |
B |
$12.32 |
$246,400 |
I/I |
20,000 |
11,355,586 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2020-05-07 |
4 |
B |
$9.87 |
$246,750 |
I/I |
25,000 |
14,734,942 |
2.25 |
% |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2021-11-22 |
4 |
B |
$5.06 |
$247,874 |
I/I |
48,987 |
17,284,913 |
2.25 |
% |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2013-08-15 |
4 |
B |
$7.72 |
$248,955 |
I/I |
32,248 |
9,130,973 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2016-05-13 |
4 |
B |
$12.45 |
$249,000 |
I/I |
20,000 |
12,045,377 |
2.25 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2009-11-13 |
4 |
B |
$10.00 |
$250,000 |
D/D |
25,000 |
3,531,672 |
2.45 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2018-02-21 |
4 |
B |
$25.16 |
$251,600 |
I/I |
10,000 |
13,155,028 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2018-02-22 |
4 |
B |
$25.21 |
$252,100 |
I/I |
10,000 |
13,165,028 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2021-12-20 |
4 |
B |
$4.73 |
$257,979 |
I/I |
54,541 |
18,450,631 |
2.25 |
% |
|
SLNO |
Soleno Therapeutics Inc |
10% Owner |
|
2019-03-21 |
4 |
B |
$2.32 |
$258,275 |
I/I |
111,407 |
111,407 |
1.5 |
- |
|
QDEL |
QuidelOrtho Corporation |
Director |
|
2009-05-28 |
4 |
B |
$12.14 |
$259,082 |
I/I |
21,334 |
225,835 |
2.1 |
- |
|
QDEL |
QuidelOrtho Corporation |
Director |
|
2012-03-20 |
4 |
B |
$16.48 |
$260,577 |
D/D |
15,815 |
3,271,465 |
2.39 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2014-06-30 |
4 |
B |
$26.09 |
$260,900 |
I/I |
10,000 |
10,649,992 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2017-10-17 |
4 |
B |
$20.29 |
$268,843 |
I/I |
13,250 |
12,995,117 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2016-02-02 |
4 |
B |
$13.46 |
$269,200 |
I/I |
20,000 |
11,268,178 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2020-05-14 |
4 |
B |
$9.20 |
$272,108 |
I/I |
29,577 |
16,633,101 |
2.25 |
% |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2013-08-21 |
4 |
B |
$1.40 |
$278,961 |
D/D |
199,586 |
7,263,735 |
2.45 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2018-11-09 |
4 |
A |
$14.37 |
$280,215 |
I/I |
19,500 |
1,630,423 |
0 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2010-06-07 |
4 |
B |
$2.56 |
$281,072 |
D/D |
110,000 |
4,562,864 |
2.45 |
- |
|
SLNO |
Soleno Therapeutics Inc |
10% Owner |
|
2021-05-05 |
4 |
S |
$1.14 |
$283,149 |
I/I |
(248,115) |
9,749,043 |
0 |
% |
|
634 Records found
|
|
Page 17 of 26 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|